Company Filing History:
Years Active: 2014-2019
Title: Innovations of Wei-Zen Wei in Cancer Treatment
Introduction
Wei-Zen Wei is a notable inventor based in Grosse Pointe Farms, MI (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented inventions. With a total of 2 patents, Wei-Zen Wei is recognized for his advancements in immunotherapy and vaccine development.
Latest Patents
Wei-Zen Wei's latest patents include groundbreaking work on HER2 antigenic polypeptide compositions. These compositions are designed for the treatment and prevention of carcinomas. His research focuses on antigenic polypeptides of the growth factor receptor HER2, which aim to break the tolerance of a host against self HER2. The polypeptides feature single amino acid substitutions, enhancing their effectiveness in immunization methods. Additionally, he has developed a vaccine targeting the cellular death receptor DR5, which induces the production of antibodies to cause the apoptotic death of target cells. This innovative approach has potential applications in both therapeutic and prophylactic settings.
Career Highlights
Wei-Zen Wei is affiliated with Wayne State University, where he continues to advance his research in cancer therapies. His work has garnered attention for its potential to improve immunocompetence in mammalian subjects, paving the way for more effective cancer treatments.
Collaborations
Wei-Zen Wei collaborates with esteemed colleagues, including Richard Donovan Jones and Gen Sheng Wu. Their combined expertise contributes to the innovative research being conducted at Wayne State University.
Conclusion
Wei-Zen Wei's contributions to cancer treatment through his patented inventions highlight the importance of innovation in medical research. His work not only advances scientific understanding but also offers hope for improved therapies for cancer patients.